Researchers made CD5/CD7 CAR-T cells that showed anti-tumor substantial effects in malignant T cell lines such as Jurkat, CCRF-CEM, MOLT, and in xenogeneic mouse models established using CCRF-CEM-ffLuc cell injections [66]. Here, CD5 is linked to neoplasm.